<DOC>
	<DOCNO>NCT02354027</DOCNO>
	<brief_summary>The purpose study investigate potential interaction multiple oral dos SHR3824 single oral dose metformin healthy adult volunteer .</brief_summary>
	<brief_title>The Drug-drug Interaction SHR3824 Metformin</brief_title>
	<detailed_description>This open-label ( volunteer know name treatment assign ) single-center study SHR3824 metformin healthy adult volunteer . SHR3824 ( Sodium-Glucose Cotransporter 2 inhibitor ) currently development low blood sugar level patient type 2 diabetes mellitus ( T2DM ) metformin approved treatment patient T2DM . SHR3824 administer orally ( mouth ) 25 mg Days 4 , 5 , 6 , 7 , 8 metformin administer orally two 500mg tablet Days 1 8 . Both SHR3824 metformin tablet take 8 ounce ( 240 mL ) water .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy volunteer body mass index ( BMI , measure person 's weight relation height ) 19 24 kg/m2 . History diabetes History heart failure renal insufficiency Urinary tract infection , vulvovaginal mycotic infection History current clinically significant medical illness determine Investigator History clinically significant allergy , especially know hypersensitivity intolerance lactose Known allergy SHR3824 metformin excipients formulation SHR3824 metformin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>SHR3824 metformin drug-drug interaction</keyword>
</DOC>